Total Payments
$11,245
2024 Payments
$2,746
Companies
43
Transactions
665
Medicare Patients
1,077
Medicare Billing
$63,423
Payment Breakdown by Category
Food & Beverage$11,245 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,245 | 665 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,146 | 141 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,493 | 60 | $0 (2024) |
| PFIZER INC. | $1,213 | 68 | $0 (2024) |
| Amgen Inc. | $901.46 | 69 | $0 (2024) |
| Lilly USA, LLC | $899.79 | 63 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $591.13 | 33 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $464.71 | 25 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $374.94 | 22 | $0 (2024) |
| Novo Nordisk Inc | $341.71 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $332.28 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,746 | 143 | PFIZER INC. ($542.45) |
| 2023 | $2,893 | 171 | ABBVIE INC. ($549.36) |
| 2022 | $2,357 | 144 | ABBVIE INC. ($644.70) |
| 2021 | $3,250 | 207 | AbbVie Inc. ($559.76) |
All Payment Transactions
665 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: PAIN | ||||||
| 12/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: VACCINES | ||||||
| 12/12/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.85 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.06 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: PAIN | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.36 | General |
| Category: PAIN | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: PAIN | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: PAIN | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.33 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 429 | 467 | $72,383 | $28,384 |
| 2022 | 10 | 347 | 378 | $54,050 | $17,587 |
| 2021 | 7 | 224 | 270 | $40,640 | $13,639 |
| 2020 | 3 | 77 | 79 | $11,370 | $3,813 |
Total Patients
1,077
Total Services
1,194
Medicare Billing
$63,423
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 87 | 87 | $20,955 | $8,868 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 114 | $17,100 | $4,877 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 81 | $17,415 | $4,874 | 28.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $4,500 | $3,395 | 75.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 15 | $3,675 | $1,924 | 52.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 21 | 21 | $1,953 | $1,592 | 81.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 75 | 75 | $3,375 | $1,084 | 32.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 32 | $1,760 | $914.24 | 51.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 30 | 30 | $1,650 | $857.10 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 56 | 56 | $14,280 | $5,835 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 120 | $18,000 | $4,327 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 49 | $10,535 | $2,515 | 23.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 14 | $3,430 | $1,708 | 49.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 18 | 18 | $1,350 | $1,234 | 91.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 51 | 51 | $2,295 | $740.76 | 32.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 19 | $1,045 | $520.22 | 49.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $660.00 | $330.24 | 50.0% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 14 | 14 | $2,080 | $290.01 | 13.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 23 | 25 | $375.00 | $86.27 | 23.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 101 | 140 | $21,000 | $6,381 | 30.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 40 | $8,600 | $2,590 | 30.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 22 | 22 | $5,610 | $2,342 | 41.8% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 11 | 11 | $2,695 | $1,457 | 54.1% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 15 | 16 | $1,600 | $565.28 | 35.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 13 | 13 | $715.00 | $206.18 | 28.8% |
About Chi-Ying Sage, ARNP
Chi-Ying Sage, ARNP is a Family healthcare provider based in Waterloo, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2020. The National Provider Identifier (NPI) number assigned to this provider is 1831722370.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chi-Ying Sage, ARNP has received a total of $11,245 in payments from pharmaceutical and medical device companies, with $2,746 received in 2024. These payments were reported across 665 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($11,245).
As a Medicare-enrolled provider, Sage has provided services to 1,077 Medicare beneficiaries, totaling 1,194 services with total Medicare billing of $63,423. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Waterloo, IA
- Active Since 02/12/2020
- Last Updated 05/14/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831722370
Products in Payments
- UBRELVY (Drug) $1,037
- BREZTRI (Drug) $855.29
- Otezla (Drug) $611.40
- JARDIANCE (Drug) $593.29
- QULIPTA (Drug) $587.92
- ELIQUIS (Drug) $561.63
- NURTEC ODT (Drug) $508.54
- XARELTO (Drug) $464.71
- VRAYLAR (Drug) $457.68
- FARXIGA (Drug) $422.35
- EMGALITY (Drug) $325.09
- MOUNJARO (Drug) $305.93
- ENTRESTO (Drug) $238.76
- TRELEGY ELLIPTA (Drug) $233.66
- AIRSUPRA (Drug) $215.42
- Kerendia (Drug) $207.40
- VOQUEZNA (Drug) $195.72
- Aimovig (Biological) $194.94
- CAMZYOS (Drug) $177.13
- Cologuard Collection Kit (Device) $160.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Waterloo
Michaela Johnson, Arnp, ARNP
Family — Payments: $7,312
Family $7,312
Ute Gallert, Fnp, FNP
Family — Payments: $4,576
Family $4,576
Megan O'neal, Arnp, ARNP
Family — Payments: $4,412
Family $4,412
Roberta Korich, N.p, N.P
Family — Payments: $3,092
Family $3,092
Sue Green, Fnp, FNP
Family — Payments: $2,483
Family $2,483
Shanna Witges, Aprn Np-C, APRN NP-C
Family — Payments: $2,471
Family $2,471